Shanghai Rendu Biotechnology Co., Ltd. (SHA:688193)
China · Delayed Price · Currency is CNY 53.23
-0.71 (-1.32%)
At close: Feb 26, 2026
SHA:688193 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -5.47 | -7.81 | 8.26 | 23.33 | 64.62 | 61.38 |
Depreciation & Amortization | 16.9 | 16.9 | 15.57 | 14.45 | 10.02 | 5.79 |
Other Amortization | 2.65 | 2.65 | 2 | 1.5 | 0.77 | 0.12 |
Loss (Gain) From Sale of Assets | -0.14 | -0.14 | 0.05 | -0.14 | -0.76 | -0.51 |
Asset Writedown & Restructuring Costs | 0.83 | 0.83 | 0.34 | 1.19 | 0.38 | 0.29 |
Loss (Gain) From Sale of Investments | -10.49 | -10.49 | -6.16 | -9.32 | -1.21 | -1.08 |
Provision & Write-off of Bad Debts | 16.83 | 16.83 | 0.59 | 2.92 | 1.01 | 0.73 |
Other Operating Activities | -10.34 | 2.82 | 0.43 | 1 | 0.76 | 0.92 |
Change in Accounts Receivable | 9.45 | 9.45 | 26.66 | -49 | -19.57 | -17.43 |
Change in Inventory | 2.49 | 2.49 | 0.05 | -10.09 | -2.8 | -5.25 |
Change in Accounts Payable | -4.13 | -4.13 | -21.42 | 22.32 | -9.63 | 35.95 |
Change in Other Net Operating Assets | 2.28 | 2.28 | -4.16 | 2.42 | 7.95 | 2.97 |
Operating Cash Flow | 13.57 | 24.39 | 17.19 | -4.09 | 54.44 | 92.61 |
Operating Cash Flow Growth | -70.36% | 41.85% | - | - | -41.21% | 577.69% |
Capital Expenditures | -7.15 | -10.52 | -20.39 | -21.22 | -26.48 | -15.55 |
Sale of Property, Plant & Equipment | 1.12 | 1.12 | 0.39 | 0.7 | 1.94 | 0.95 |
Cash Acquisitions | - | - | - | - | - | 0.47 |
Investment in Securities | -101.54 | -323.75 | 315 | -530 | -0.13 | 32 |
Other Investing Activities | 14.24 | 11.17 | 6.92 | 8.83 | 1.21 | 1.2 |
Investing Cash Flow | -93.33 | -321.99 | 301.92 | -541.68 | -23.45 | 19.07 |
Short-Term Debt Issued | - | - | - | - | - | 3.84 |
Total Debt Issued | - | - | - | - | - | 3.84 |
Short-Term Debt Repaid | - | - | - | - | -3.84 | -1.45 |
Long-Term Debt Repaid | - | -3.27 | -3.97 | -1.26 | -1.98 | - |
Total Debt Repaid | -3.27 | -3.27 | -3.97 | -1.26 | -5.82 | -1.45 |
Net Debt Issued (Repaid) | -3.27 | -3.27 | -3.97 | -1.26 | -5.82 | 2.39 |
Issuance of Common Stock | 2.63 | - | - | 675.69 | - | - |
Repurchase of Common Stock | -35.66 | -35.66 | - | - | - | - |
Common Dividends Paid | -7.64 | -11.71 | -5 | - | -0.05 | -0.14 |
Other Financing Activities | 35.45 | - | - | -27.14 | 0.91 | 16.79 |
Financing Cash Flow | -8.49 | -50.64 | -8.97 | 647.29 | -4.97 | 19.04 |
Foreign Exchange Rate Adjustments | 1.68 | 0.56 | 0.48 | -0.15 | -0.36 | -0.97 |
Net Cash Flow | -86.57 | -347.69 | 310.63 | 101.37 | 25.67 | 129.75 |
Free Cash Flow | 6.42 | 13.86 | -3.2 | -25.31 | 27.97 | 77.06 |
Free Cash Flow Growth | -75.69% | - | - | - | -63.71% | - |
Free Cash Flow Margin | 3.87% | 7.82% | -1.94% | -8.33% | 9.57% | 30.84% |
Free Cash Flow Per Share | 0.16 | 0.35 | -0.08 | -0.66 | 0.92 | 2.56 |
Cash Income Tax Paid | 12.95 | 6.9 | 7.34 | 18.84 | 17.9 | 9.2 |
Levered Free Cash Flow | 64.33 | 18.4 | -10.09 | -29.74 | -3.93 | 48.83 |
Unlevered Free Cash Flow | 64.52 | 18.59 | -9.82 | -29.51 | -3.77 | 48.88 |
Change in Working Capital | 2.8 | 2.8 | -3.91 | -39.03 | -21.14 | 24.97 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.